Guo et al. present findings showing that miR-153 is significantly overexpressed in patients with nasopharyngeal carcinoma (NPC), more so this miRNA affects NPC progression through the transforming growth factor-beta 2 (TGF-β2)/Smad2 signaling pathway [28]. This evidence concerns the gene SMAD2 and nasopharyngeal carcinoma.